Search





Search





News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

Cibus (CBUS) Q2 2026 Earnings Call: Rice Launch Moves to 2028 as Costs Decline

Cibus (CBUS) Q2 2026 revenue reached $1.0 million as costs fell, while its Latin America rice launch moved to 2028 and cash runway extends into early Q1 2027.

TradingKey

Fri, Aug 14

Co-Diagnostics (CODX) Q2 2026 Earnings Call: FDA Filing Advances as Cash Falls

Co-Diagnostics Q2 2026 revenue reached $166,000 as losses narrowed, while CODX filed its flu and RSV assay with the FDA and ended with $3.6 million in cash.

Co-Diagnostics Inc

TradingKey

Fri, Aug 14

Cellebrite (CLBT) Q2 2026 Earnings Call: Guidance Cut as ARR Reaches $508 Million

Cellebrite Q2 2026 earnings call: ARR rose 21% to $508 million, revenue increased 16%, guidance was cut, and Shiv Ramji was appointed CEO.

Cellebrite DI Ltd

TradingKey

Fri, Aug 14

Cerebras Systems (CBRS) Fiscal Q2 2026 Earnings Call: Revenue Doubles, Outlook Raised

Cerebras Systems' fiscal Q2 2026 earnings call covered 103% core revenue growth, $25.4 billion of RPO, capacity expansion and raised 2026 guidance.

Cerebras Systems Ord Shs Class A (Proposed)

TradingKey

Fri, Aug 14

Capricor Therapeutics (CAPR) Q2 2026 Earnings Call: Deramocel BLA Path and FDA Update

Capricor Therapeutics’ Q2 2026 earnings call covered its deramocel BLA amendment plan, $237.9 million cash balance and $40.7 million net loss.

Capricor Therapeutics Inc

TradingKey

Fri, Aug 14

Blaize Holdings (BZAI) Q2 2026 Earnings Call: Revenue Guidance Cut to $40M-$43M

Blaize Holdings’ Q2 2026 earnings call covered $12 million revenue, an 8% gross margin, sharply reduced 2026 guidance and about $50 million of expected backlog.

Blaize Holdings Inc

TradingKey

Fri, Aug 14

BitGo (BTGO) Q2 2026 Earnings Call: Revenue Rises as Margins Compress

BitGo Q2 2026 revenue rose 79.6% to $4.3 billion, but trading and staking margins weakened. Management targets lower Q3 costs and near break-even EBITDA.

BitGo Holdings Ord Shs Class A

TradingKey

Fri, Aug 14

Bit Digital (BTBT) Q2 2026 Earnings Call: Cloud Growth, White Fiber Financing and Buyback Review

Bit Digital Q2 2026 revenue rose 15% to $32.1 million as cloud services expanded, while management reviewed White Fiber financing and a potential buyback.

Bit Digital Inc

TradingKey

Fri, Aug 14

Brookfield Corporation (BN) Q2 2026 Earnings Call: DE Rises 15% as AI and Insurance Expand

Brookfield Corporation’s Q2 2026 earnings call covered 15% DE growth, record fundraising, $190 billion of insurance assets and expanding AI infrastructure plans.

Brookfield Corp

TradingKey

Fri, Aug 14

Bullish (BLSH) Q2 2026 Earnings Call: Revenue Up 62%, Tokenization Advances

Bullish Q2 2026 adjusted revenue rose 62% to $92.6 million as management advanced tokenized equities, U.S. derivatives access and Equiniti.

TradingKey

Fri, Aug 14

Belite Bio (BLTE) Q2 2026 Earnings Call: Tinlarebant FDA Review and $780M Cash

Belite Bio Q2 2026 earnings call: FDA priority review for Tinlarebant, a February 12, 2027 PDUFA date, $780 million in cash and higher expenses.

TradingKey

Fri, Aug 14

Bridgeline Digital (BLIN) Q3 FY2026 Earnings Call: Core Revenue Growth Narrows Losses

Bridgeline Digital’s Q3 FY2026 revenue rose to $3.9 million, core revenue reached $2.4 million, and adjusted EBITDA loss narrowed to $102,000.

Bridgeline Digital Inc

TradingKey

Fri, Aug 14

Birkenstock (BIRK) Fiscal Q3 2026 Earnings Call: Revenue Guidance Raised

Birkenstock fiscal Q3 2026 revenue rose 15% in constant currency as DTC accelerated. Management raised full-year EBITDA guidance to at least €710 million.

Birkenstock Holding PLC

TradingKey

Fri, Aug 14

Biofrontera (BFRI) Q2 2026 Earnings Call: Revenue Up 33%, Gross Margin Reaches 80%

Biofrontera’s Q2 2026 earnings call covered 33% revenue growth, an 80% gross margin, near-breakeven adjusted EBITDA, ITC restrictions and Ameluz milestones.

Biofrontera Inc

TradingKey

Fri, Aug 14

AVAX One (AVX) Q2 2026 Earnings Call: Revenue Rises as Digital Asset Losses Weigh

AVAX One Q2 2026 revenue rose to $2.8 million, while digital asset losses drove a $35.1 million net loss. Review liquidity, staking and AI plans.

Avax One Technology Ord Shs

TradingKey

Fri, Aug 14

BETA Technologies Q2 2026 Earnings Call: Revenue Growth, $3.9 Billion Backlog and Higher Guidance

BETA Technologies Q2 2026 earnings call: revenue rose 146% to $14.7 million, backlog reached $3.9 billion, and full-year guidance increased.

BETA Technologies Inc

TradingKey

Fri, Aug 14

HeartBeam (BEAT) Q2 2026 Earnings Call: FDA Filing, Lower Cash Burn and Commercial Launch

HeartBeam’s Q2 2026 earnings call covered a $5 million net loss, lower cash burn, FDA progress and early commercial rollout across four U.S. markets.

TradingKey

Fri, Aug 14

Birch Tech (BCHT) Q2 2026 Earnings Call: Revenue Reaches $3.8M

Birch Tech’s Q2 2026 earnings call covered $3.8 million in revenue, a $3.0 million net loss, patent resolutions and plans to scale water treatment.

Birchtech Ord Shs

TradingKey

Fri, Aug 14

BioCardia (BCDA) Q2 2026 Earnings Call: CardiAMP Japan Filing and FDA Progress

BioCardia’s Q2 2026 earnings call covered Japan’s CardiAMP filing, FDA pathways for CardiAMP and Helix, a narrower net loss and cash runway into 2027.

TradingKey

Fri, Aug 14

Atea Pharmaceuticals (AVIR) Q2 2026 Earnings Call: C-BEYOND Meets Phase 3 Endpoint

Atea Pharmaceuticals’ Q2 2026 earnings call covered positive Phase 3 C-BEYOND HCV data, $219.5 million in cash and key 2027 regulatory milestones.

Atea Pharmaceuticals Inc

TradingKey

Fri, Aug 14

1...33 34 35

35/37

Featured Tools

marketing_marketsTitle

calendar_economicCalendar

Economic Calendar

search.intelligent.strategy

article_asider_weekly_report

Popular Instruments

link

Name

Price

Chg%

link

Meta Q3 Net Profit Surges 264% YoY, Raises Full-Year Capex Slightly; Shares Briefly Rise Over 4% After Hours

Tesla Q3 Operating Profit Plunges 56% YoY, Dragged Down by Higher Operating Expenses Including R&D

Meta Q3 2026 Earnings: Legal Charge Halves Operating Margin Despite 26% Revenue Growth

US Stocks Close: Nasdaq Gains Over 1%, Philadelphia Semiconductor Index Rises Nearly 2%; Tech Stocks Strengthen, SpaceX Gains Nearly 8% Post-Earnings

Meta Q3 Earnings Preview: Muse Commercialization Faces Test, Wall Street High Target Price Hits $1,000

link

Silver/AUD (XAGAUD) Is down 2.12% on Oct 22: What Is Driving the Move?

17 minutes ago

Micro Silver (XAGUSD-M) Moved Sharply on Oct 22: Inventories, the Dollar, or Geopolitics?

47 minutes ago

Silver (XAGUSD) Drops on Oct 22: What Lie behind the Move?

52 minutes ago

Palladium (XPDUSD) Is down 2.53% on Oct 22: Is the Market Repricing It?

57 minutes ago

Bitcoin (BTCUSD) Volatility Intensified on Oct 22: What You Should Know

an hour ago